D-K6L9
Description
D-K6L9 has antimicrobial and anti-biofilm activity against Pseudomonas aeruginosa (P. aeruginosa) from cystic fibrosis patients. D-K6L9 is stable, resistant to degradation by cystic fibrosis sputum proteases, and does not induce bacterial resistance.
Product Details
| Product Name | D-K6L9 |
| Biological activity | D-K6L9 shows antimicrobial and antibiofilm activities against P. aeruginosa from cystic fibrosis patients. D-K6L9 is stable and resistant to degradation by cystic fibrosis sputum proteases and will not induce bacterial resistance . |
| Sequence | Leu-Lys-{d-Leu}-Leu-Lys-{d-Lys}-Leu-{d-Leu}-{d-Lys}-Lys-Leu-Leu-{d-Lys}-Leu-Leu-NH2 |
| Sequence Shortening | LK-{d-Leu}-LK-{d-Lys}-L-{d-Leu}-{d-Lys}-KLL-{d-Lys}-LL-NH2 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
